Cornell Scientists Achieve Major Breakthrough in Reversible Male Contraception

Cornell University researchers have developed a nonhormonal male contraceptive that proved 100% effective, safe, reversible, and long-acting in a six-year proof-of-principle study conducted in mice. The contraceptive works by targeting a natural checkpoint in meiosis, the process by which sex cells reproduce, safely stopping sperm production without hormonal intervention. Published in the Proceedings of the National Academy of Sciences, the results represent what researchers consider significant progress toward the holy grail of male contraception—a safe, reversible, long-acting nonhormonal option. The breakthrough addresses a major gap in contraceptive choices available to men.

Development of Nonhormonal Male Contraceptive

• ▪The Cornell scientists' proof-of-principle study on male contraception took six years to complete
• ▪A nonhormonal male contraceptive that is safe, reversible, long-acting and 100% effective is considered the holy grail of male contraception
• ▪Cornell scientists have developed a nonhormonal male contraceptive that is safe, reversible, long-acting and 100% effective

Research Methodology and Mechanism

• ▪The Cornell scientists' male contraceptive works by targeting a natural checkpoint in meiosis
• ▪The Cornell scientists' proof-of-principle study on male contraception was conducted in mice
• ▪Targeting a natural checkpoint in meiosis safely stopped sperm production in the Cornell scientists' study
• ▪Meiosis is the process by which sex cells reproduce

Significance and Future Implications

• ▪The Cornell scientists' male contraception study is published in the journal Proceedings of the National Academy of Sciences

Perspective of Cornell University researchers

• ▪The Cornell researchers' proof-of-concept results represent progress toward the holy grail of male contraception
• ▪The Cornell researchers' nonhormonal male contraceptive represents a significant step toward developing new contraceptive options